Citation: | ZHANG Jiyun, ZHANG Jinxing, ZHANG Hua, MA Binlin, SUN Gang. Research on expressions of estrogen receptor, progesterone receptor and C-erbB-2 in primary lesions and contemporary axillary lymph node metastasis lesions between Uygur nationality and Han nationality female patients with breast cancer in Xinjiang area[J]. Journal of Clinical Medicine in Practice, 2019, 23(10): 9-11. DOI: 10.7619/jcmp.201910003 |
[1] |
舒文环, 仲伟霞. 乳腺癌原发灶与转移灶HR和HER-2一致性的研究现状[J]. 中华肿瘤防治杂志, 2011, 18(9): 734-736. https://www.cnki.com.cn/Article/CJFDTOTAL-QLZL201109029.htm
|
[2] |
高济越, 马振海. ER、PR、Her-2及Ki-67在乳腺癌原发灶及同期腋窝淋巴结转移灶中表达一致性的研究进展[J]. 医学综述, 2015, 21(13): 2363-2366. doi: 10.3969/j.issn.1006-2084.2015.13.023
|
[3] |
Falck A K, Fern M, Bendahl P O, et al. Does analysis of biomarkers in tumor cells in lymph node metastases give additional prognostic information in primary breast cancer[J]. World J Surg, 2010, 34(7): 1434-1441. doi: 10.1007/s00268-010-0499-z
|
[4] |
《乳腺癌Her-2检测指南》编写组. 乳腺癌Her-2检测指南(2009版)[J]. 中华病理学杂志, 2009, 38(12): 836-840. doi: 10.3760/cma.j.issn.0529-5807.2009.12.013
|
[5] |
赵海波, 程雪雁. 乳腺癌原发灶与腋淋巴结转移灶ER和PR及C-erbB-2表达的对照研究[J]. 中华肿瘤防治杂志, 2015, 18(8): 594-596. https://www.cnki.com.cn/Article/CJFDTOTAL-QLZL201108009.htm
|
[6] |
Aitken S J, Thomas J S, Langdon S P, et al. Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases[J]. Ann Oncol, 2010, 21(6): 1254-1261. doi: 10.1093/annonc/mdp427
|
[7] |
Gomez-Fernandez C, Daneshbod Y, Nassiri M, et al. Immunohistochemically determined estrogen receptor phenotype remains stable in recurrent and metastatic breast cancer[J]. Am J Clin Pathol, 2008, 130(6): 879-882. doi: 10.1309/AJCPD1AO3YSYQYNW
|
[8] |
Broom R J, Tang P A, Simmons C, et al. Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer[J]. Anticancer Res, 2009, 29(5): 1557-1562. http://europepmc.org/abstract/med/19443366
|
[9] |
Guarneri V, Giovannelli S, Ficarra G, et al. Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management[J]. Oncologist, 2008, 13(8): 838-844. doi: 10.1634/theoncologist.2008-0048
|
[10] |
张继运, 李飞. 新疆汉族与维吾尔族三阴性乳腺癌病理特征对比分析[J] 山东医药, 2012, 52(40): 85-86. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYY201240032.htm
|
[11] |
刘琪, 左文述, 王新昭, 等. 乳腺癌原发灶和淋巴结转移灶激素受体及Her-2与Ki-67表达相关性分析[J]. 中华肿瘤防治杂志, 2013, 20(15): 1153-1157. https://www.cnki.com.cn/Article/CJFDTOTAL-QLZL201315011.htm
|
[12] |
李强. 细针穿刺检测乳腺癌原发灶和转移灶ER、PR及C-erbB-2受体表达差异的意义[J]. 肿瘤基础与临床, 2011, 24(5): 382-384. doi: 10.3969/j.issn.1673-5412.2011.05.005
|
[13] |
Pusztai L, Viale G, Kelly C M, et al. Estrogen and HER-2 receptor discordance between primary breast cancer and metastasis[J]. Oncologist, 2015, 15(11): 1164-1168. doi: 10.1634/theoncologist.2010-0059
|
[14] |
姚自翔, 金梁斌. 乳腺癌原发灶与同期腋淋巴结转移灶雌、孕激素受体和人类表皮生长因子受体2的表达差异研究[J]. 中华内分泌杂志, 2014, 8(2): 134-136.
|
1. |
张洋洋,谭丽艳,南晓利,柳扬. 血脂相关指标与糖尿病视网膜病变的相关研究进展. 中国医药科学. 2024(19): 32-35 .
![]() | |
2. |
王灵悦. 眼动脉超声血流参数诊断T2DM合并视网膜病变及对病变程度的评估价值. 实用临床医学. 2024(06): 59-63 .
![]() | |
3. |
柏旭,苏洁,李凤,徐倩,沈源,肖凌凤. 我国成人糖尿病视网膜病变影响因素的Meta分析. 预防医学. 2023(07): 595-601 .
![]() | |
4. |
郭婧,李芸云,刘思思,沙颖,马凯,王红. 糖尿病视网膜病变不同分期患者血清δ样蛋白4和环磷腺苷效应元件结合蛋白水平对微血管损伤的预测价值. 实用临床医药杂志. 2023(23): 68-72+78 .
![]() |